Rongqi Sun

822 total citations
19 papers, 560 citations indexed

About

Rongqi Sun is a scholar working on Surgery, Molecular Biology and Oncology. According to data from OpenAlex, Rongqi Sun has authored 19 papers receiving a total of 560 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Surgery, 10 papers in Molecular Biology and 9 papers in Oncology. Recurrent topics in Rongqi Sun's work include Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Rongqi Sun is often cited by papers focused on Cholangiocarcinoma and Gallbladder Cancer Studies (15 papers), MicroRNA in disease regulation (7 papers) and Pancreatic and Hepatic Oncology Research (4 papers). Rongqi Sun collaborates with scholars based in China, India and Ethiopia. Rongqi Sun's co-authors include Zengli Liu, Jia Fan, Yunfei Xu, Jian Zhou, Zheng‐Jun Zhou, Shao‐Lai Zhou, Tianli Chen, Zongli Zhang, Haoyang Xin and Chu‐Bin Luo and has published in prestigious journals such as Nature Communications, SHILAP Revista de lepidopterología and Hepatology.

In The Last Decade

Rongqi Sun

19 papers receiving 556 citations

Peers

Countries citing papers authored by Rongqi Sun

Since Specialization

Citations

This map shows the geographic impact of Rongqi Sun's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Rongqi Sun with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Rongqi Sun more than expected).

Fields of papers citing papers by Rongqi Sun

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Rongqi Sun. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Rongqi Sun. The network helps show where Rongqi Sun may publish in the future.

Co-authorship network of co-authors of Rongqi Sun

This figure shows the co-authorship network connecting the top 25 collaborators of Rongqi Sun. A scholar is included among the top collaborators of Rongqi Sun based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Rongqi Sun. Rongqi Sun is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

19 of 19 papers shown

#	Work	Indexed citations
1	Whole-exome sequencing reveals genomic landscape of intrahepatic cholangiocarcinoma and identifies SAV1 as a potential driver 2024 ·Nature Communications ·Zheng‐Jun Zhou, (unknown), Zhiqiang Hu, Yayi Hou, (unknown), Rongqi Sun, Pengcheng Wang, Chu‐Bin Luo, Jia Li, (unknown), Jian Zhou, Jia Fan, Chengli Song, Shao‐Lai Zhou	4
2	Integrated molecular characterization of sarcomatoid hepatocellular carcinoma 2024 ·Clinical and Molecular Hepatology ·Rongqi Sun, (unknown), Ye Xu, Bo Wang, Si-Yuan Pan, Ning Li, Long Chen, (unknown), Zhiqiang Hu, (unknown), Zheng‐Jun Zhou, Jian Zhou, Chengli Song, Shao‐Lai Zhou	2
3	Development and validation of a stromal-immune signature to predict prognosis in intrahepatic cholangiocarcinoma 2024 ·Clinical and Molecular Hepatology ·(unknown), Haoyang Xin, (unknown), Ning Li, Si-Yuan Pan, Long Chen, (unknown), Zhiqiang Hu, Pengcheng Wang, Chu‐Bin Luo, Rongqi Sun, (unknown), Jian Zhou, Zheng‐Jun Zhou, Shao‐Lai Zhou	1
4	Characterization of tumor microbiome and associations with prognosis in intrahepatic cholangiocarcinoma 2024 ·Journal of Gastroenterology ·Haoyang Xin, (unknown), Rongqi Sun, Zhiqiang Hu, Zhuo Chen, Chu‐Bin Luo, Zheng‐Jun Zhou, Pengcheng Wang, Jia Li, Songyang Yu, (unknown), Jia Fan, Jian Zhou, Shao‐Lai Zhou	8
5	LRP4 mutations promote tumor progression and resistance to anti-PD-1 therapy in recurrent hepatocellular carcinoma 2024 ·Hepatology ·Rongqi Sun, (unknown), Si-Yuan Pan, (unknown), Ning Li, (unknown), (unknown), Yuxi Zhang, Long Chen, (unknown), (unknown), Chu‐Bin Luo, (unknown), Zheng‐Jun Zhou, Shao‐Lai Zhou, Jian Zhou	2
6	Association of BRAF Variants With Disease Characteristics, Prognosis, and Targeted Therapy Response in Intrahepatic Cholangiocarcinoma 2023 ·JAMA Network Open ·Haoyang Xin, Rongqi Sun, (unknown), Pengcheng Wang, Jiayin Wang, (unknown), (unknown), Zhiqiang Hu, Zheng‐Jun Zhou, Jia Fan, Jian Zhou, Shao‐Lai Zhou	22
7	Tumor‐derived exosomes induce immunosuppressive macrophages to foster intrahepatic cholangiocarcinoma progression 2022 ·Hepatology ·Chu‐Bin Luo, Haoyang Xin, Zheng‐Jun Zhou, Zhiqiang Hu, Rongqi Sun, Na Yao, Qi‐Man Sun, Uyunbilig Borjigin, Xia Wu, Jia Fan, Xiaowu Huang, Shao‐Lai Zhou, Jian Zhou	78
8	WDR5 facilitates EMT and metastasis of CCA by increasing HIF-1α accumulation in Myc-dependent and independent pathways 2021 ·Molecular Therapy ·Tianli Chen, Kangshuai Li, Zengli Liu, Jialiang Liu, Yue Wang, Rongqi Sun, Zhipeng Li, Bo Qiu, Xiaoming Zhang, Guangli Ren, Yunfei Xu, Zongli Zhang	57
9	Decreased expression of serum semaphorin 3B is associated with poor prognosis of patients with hepatocellular carcinoma 2021 ·Experimental and Therapeutic Medicine ·Guangzhen Li, Di Shen, Guanghong Li, Wei Meng, (unknown), Zengli Liu, Rongqi Sun, (unknown), Zongli Zhang, (unknown)	5
10	Characterization of immune infiltration in sarcomatoid hepatocellular carcinoma 2021 ·Aging ·Chu‐Bin Luo, Haoyang Xin, Dan Yin, (unknown), Zhiqiang Hu, Zheng‐Jun Zhou, Rongqi Sun, Na Yao, Qi‐Man Sun, Jia Fan, Xiaowu Huang, Jian Zhou, Shao‐Lai Zhou	12
11	HMGA1-TRIP13 axis promotes stemness and epithelial mesenchymal transition of perihilar cholangiocarcinoma in a positive feedback loop dependent on c-Myc 2021 ·Journal of Experimental & Clinical Cancer Research ·Zhipeng Li, Jialiang Liu, Tianli Chen, Rongqi Sun, Zengli Liu, Bo Qiu, Yunfei Xu, Zongli Zhang	45
12	Genomic evolution and the impact of SLIT2 mutation in relapsed intrahepatic cholangiocarcinoma 2021 ·Hepatology ·Shao‐Lai Zhou, Chu‐Bin Luo, Chengli Song, Zheng‐Jun Zhou, Haoyang Xin, Zhiqiang Hu, Rongqi Sun, Jia Fan, Jian Zhou	13
13	Association of KRAS Variant Subtypes With Survival and Recurrence in Patients With Surgically Treated Intrahepatic Cholangiocarcinoma 2021 ·JAMA Surgery ·Shao‐Lai Zhou, Haoyang Xin, Rongqi Sun, Zheng‐Jun Zhou, Zhiqiang Hu, Chu‐Bin Luo, Pengcheng Wang, Jia Li, Jia Fan, Jian Zhou	39
14	Tumor-associated neutrophils and macrophages interaction contributes to intrahepatic cholangiocarcinoma progression by activating STAT3 2021 ·Journal for ImmunoTherapy of Cancer ·Zheng‐Jun Zhou, Pengcheng Wang, Rongqi Sun, (unknown), Zhiqiang Hu, Haoyang Xin, Chu‐Bin Luo, Jian Zhou, Jia Fan, Shao‐Lai Zhou	98
15	LINC01133 promotes hepatocellular carcinoma progression by sponging miR‐199a‐5p and activating annexin A2 2021 ·SHILAP Revista de lepidopterología ·Dan Yin, Zhiqiang Hu, Chu‐Bin Luo, Xiaoyi Wang, Haoyang Xin, Rongqi Sun, Pengcheng Wang, Jia Li, Jia Fan, Zheng‐Jun Zhou, Jian Zhou, Shao‐Lai Zhou	34
16	Sprouty4 correlates with favorable prognosis in perihilar cholangiocarcinoma by blocking the FGFR-ERK signaling pathway and arresting the cell cycle 2019 ·EBioMedicine ·Bo Qiu, Tianli Chen, Rongqi Sun, Zengli Liu, Xiaoming Zhang, Zhipeng Li, Yunfei Xu, Zongli Zhang	24
17	Transcription factor 7 promotes the progression of perihilar cholangiocarcinoma by inducing the transcription of c-Myc and FOS-like antigen 1 2019 ·EBioMedicine ·Zengli Liu, Rongqi Sun, Xiaoming Zhang, Bo Qiu, Tianli Chen, Zhipeng Li, Yunfei Xu, Zongli Zhang	42
18	Annexin10 promotes extrahepatic cholangiocarcinoma metastasis by facilitating EMT via PLA2G4A/PGE2/STAT3 pathway 2019 ·EBioMedicine ·Rongqi Sun, Zengli Liu, Bo Qiu, Tianli Chen, Zhipeng Li, Xiaoming Zhang, Yunfei Xu, Zongli Zhang	70
19	PTPN3 suppresses the proliferation and correlates with favorable prognosis of perihilar cholangiocarcinoma by inhibiting AKT phosphorylation 2019 ·Biomedicine & Pharmacotherapy ·Rongqi Sun, Tianli Chen, Meng Li, Zengli Liu, Bo Qiu, Zhipeng Li, Yunfei Xu, Chang Pan, Zongli Zhang	4

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact